Long‐Term Opioid Use After Treatment of Head and Neck Cancers: A Systematic Review and Meta‐analysis

We determined the rates of long‐term opioid use in head and neck cancer patients to better understand what characteristics increase the odds of long‐term opioid use in these patients.

• Publication year

  2025

• Venue

  Otolaryngology Head & Neck Surgery

• Publication date

  2025-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/ohn.70024PMID 41221895
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Is acetaminophen beneficial in patients with cancer pain who are on strong opioids? A randomized controlled trial.

  2023cited by this paper
• Prophylactic gabapentin during head and neck cancer therapy: a systematic review and meta-analysis

  2023cited by this paper
• Long-term opioid use in patients treated with head and neck intensity-modulated radiotherapy

  2022cited by this paper
• The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?

  2022cited by this paper
• A systematic review of assessment approaches to predict opioid misuse in people with cancer

  2022cited by this paper
• Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution

  2022cited by this paper
• Multimodal Analgesia in Head and Neck Free Flap Reconstruction: A Systematic Review

  2021cited by this paper
• Chronic opioid use following surgery for head and neck cancer patients undergoing free flap reconstruction

  2021cited by this paper
• Implications of Treatment Modality on Chronic Opioid Use Following Treatment for Head and Neck Cancer

  2020cited by this paper
• Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation

  2020cited by this paper
• Chronic opioid use after laryngeal cancer treatment

  2020cited by this paper
• Persistent and Chronic Postoperative Opioid Use in a Cohort of Patients with Oral Tongue Squamous Cell Carcinoma.

  2020cited by this paper
• Practice review: Evidence-based and effective management of pain in patients with advanced cancer

  2020cited by this paper
• Chronic Opioid Use after Laryngeal Cancer Treatment: A VA Study

  2020cited by this paper
• US National Trends in Opioid-Related Hospitalizations Among Patients With Cancer

  2019cited by this paper
• Changes in the 8th Edition of the American Joint Committee on Cancer (AJCC) Staging of Head and Neck Cancer: Rationale and Implications

  2019cited by this paper
• Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review.

  2019cited by this paper
• Data Sources

  2019cited by this paper
• Long‐term opioid use in curative‐intent radiotherapy: One‐Year outcomes in head/neck cancer patients

  2019cited by this paper
• Predicting Persistent Opioid Use, Abuse and Toxicity Among Cancer Survivors.

  2019cited by this paper
• Chronic opioid use in patients undergoing treatment for oropharyngeal cancer

  2019cited by this paper
• Effect of treatment modality on chronic opioid use in patients with T1/T2 oropharyngeal cancer

  2019influential reference
• Risk of prolonged opioid use among cancer patients undergoing curative intent radiation therapy for head and neck malignancies.

  2019cited by this paper
• Relative frequency and risk factors for long-term opioid therapy following surgery and trauma among adults: a systematic review protocol

  2018cited by this paper
• The Public and the Opioid-Abuse Epidemic.

  2018cited by this paper
• Persistent Postoperative Opioid Use in Older Head and Neck Cancer Patients

  2018cited by this paper
• Cancer pain management and the opioid crisis in America: How to preserve hard‐earned gains in improving the quality of cancer pain management

  2018cited by this paper
• Pain in Head and Neck Cancer Survivors: Prevalence, Predictors, and Quality-of-Life Impact

  2018cited by this paper
• Association between tobacco use, pain expression, and coping strategies among patients with advanced cancer

  2018cited by this paper
• Predicting the risk for aberrant opioid use behavior in patients receiving outpatient supportive care consultation at a comprehensive cancer center

  2018cited by this paper
• Short- and Long-term Opioid Use in Patients with Oral and Oropharynx Cancer

  2018influential reference
• Use of Palliative Care Earlier in the Disease Course in the Context of the Opioid Epidemic: Educational, Research, and Policy Issues

  2018cited by this paper
• Opioid prescribing practices in patients undergoing surgery for oral cavity cancer

  2018cited by this paper
• Management of Radiation Toxicity in Head and Neck Cancers.

  2017cited by this paper
• Gabapentin for chronic neuropathic pain in adults.

  2017cited by this paper
• Opioid addiction and misuse in adult and adolescent patients with cancer

  2017cited by this paper
• Chronic Opioid Use Following Surgery for Oral Cavity Cancer

  2017cited by this paper
• Assessing cumulative acute toxicity of chemoradiotherapy in head and neck cancer with or without induction chemotherapy.

  2017cited by this paper
• Longitudinal Perioperative Pain Assessment in Head and Neck Cancer Surgery

  2017cited by this paper
• The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013

  2016cited by this paper
• Identifying and assessing the risk of opioid abuse in patients with cancer: an integrative review

  2016cited by this paper
• Drug-associated delirium in cancer patients

  2013cited by this paper
• Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.

  2013influential reference
• Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths

  2012cited by this paper
• Adjuvant Analgesics in Cancer Pain: A Review

  2012cited by this paper
• Head and Neck Cancer Pain: Systematic Review of Prevalence and Associated Factors

  2012cited by this paper
• Multicenter phase II study of an opioid-based pain control program for head and neck cancer patients receiving chemoradiotherapy.

  2011cited by this paper
• Gabapentin for the treatment of pain syndrome related to radiation‐induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy

  2010cited by this paper
• Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain.

  2010cited by this paper
• Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial.

  2010cited by this paper
• Baclofen as an Adjuvant Analgesic for Cancer Pain

  2009cited by this paper
• Prevalence, Etiology, and Management of Neuropathic Pain in an Indian Cancer Hospital

  2009cited by this paper
• Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB)

  2009cited by this paper
• Use of lidocaine patches for neuropathic pain in a comprehensive cancer centre.

  2009cited by this paper
• Metallic taste phantom predicts oral pain among 5‐year survivors of head and neck cancer

  2008cited by this paper
• NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study.

  2008cited by this paper
• Management of Chronic Pain in Cancer Survivors

  2008cited by this paper
• Doxepin rinse for management of mucositis pain in patients with cancer: one week follow-up of topical therapy.

  2008cited by this paper
• The cognitive effects of opioids in cancer: a systematic review

  2008cited by this paper
• Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation.

  2007cited by this paper
• Chronic pain in the cancer survivor: a new frontier.

  2007cited by this paper
• Gabapentin and an opioid combination versus opioid alone for the management of neuropathic cancer pain: a randomized open trial.

  2007cited by this paper
• Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules.

  2006cited by this paper
• Patients' perceived health status following primary surgery for oral and oropharyngeal cancer.

  2006cited by this paper
• A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients

  2004cited by this paper
• Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review.

  2003cited by this paper
• Diphenhydramine as an analgesic adjuvant in refractory cancer pain.

  2001cited by this paper
• EMLA Reduces Acute and Chronic Pain After Breast Surgery for Cancer

  2000cited by this paper
• A double-blind evaluation of the analgesic efficacy and toxicity of oral ketorolac and diclofenac in cancer pain. The TD/10 recordati Protocol Study Group.

  1999cited by this paper
• Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients

  1999cited by this paper
• Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer

  1996cited by this paper
• Antidepressant drugs as adjuvant analgesics.

  1994cited by this paper

• No citing papers are available for this paper.